Cargando…
An investigation of the relation between catalase C262T gene polymorphism and catalase enzyme activity in leukemia patients
INTRODUCTION: Catalase (CAT), an antioxidant enzyme, catalyzes conversion of hydrogen peroxide to water and molecular oxygen, protecting cells against oxidative stress. The aim of this study was to investigate the possible association between CAT C262T polymorphism in the promoter region of the CAT...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314395/ https://www.ncbi.nlm.nih.gov/pubmed/34336022 http://dx.doi.org/10.5114/aoms.2019.89692 |
_version_ | 1783729541958598656 |
---|---|
author | Eras, Nazan Türkoz, Gozde Tombak, Anil Tiftik, Naci Yalin, Serap Berkoz, Mehmet Erden, Sema Akbas, Etem |
author_facet | Eras, Nazan Türkoz, Gozde Tombak, Anil Tiftik, Naci Yalin, Serap Berkoz, Mehmet Erden, Sema Akbas, Etem |
author_sort | Eras, Nazan |
collection | PubMed |
description | INTRODUCTION: Catalase (CAT), an antioxidant enzyme, catalyzes conversion of hydrogen peroxide to water and molecular oxygen, protecting cells against oxidative stress. The aim of this study was to investigate the possible association between CAT C262T polymorphism in the promoter region of the CAT gene and leukemia risk and to determine the relationship between CAT genotypes and CAT enzyme activities. MATERIAL AND METHODS: Genotypes of 102 cases and 112 healthy controls’ genotypes were determined by polymerase chain reaction-restriction fragment length polymorphism methods. Catalase activity was measured with the method of Aebi. RESULTS: The frequencies of the T allele among the cases and controls were 28.4% and 25.9%, respectively (p = 0.75). The frequencies of CC, CT, and TT among cases were 57.8%, 27.4%, and 14.7%, respectively, while in controls, the frequencies of CC, CT, and TT were 54.4%, 39.3%, and 6.3%, respectively, which were not significantly different. Although CAT enzyme activity was lower in leukemia patients with TT genotypes than in controls, this did not reach statistical significance (p = 0.37). CONCLUSIONS: This is the first report showing that CAT C262T polymorphism is not a genetic predisposing factor for the risk of leukemia in the Turkish population. However, additional research is needed to confirm these findings. |
format | Online Article Text |
id | pubmed-8314395 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Termedia Publishing House |
record_format | MEDLINE/PubMed |
spelling | pubmed-83143952021-07-31 An investigation of the relation between catalase C262T gene polymorphism and catalase enzyme activity in leukemia patients Eras, Nazan Türkoz, Gozde Tombak, Anil Tiftik, Naci Yalin, Serap Berkoz, Mehmet Erden, Sema Akbas, Etem Arch Med Sci Clinical Research INTRODUCTION: Catalase (CAT), an antioxidant enzyme, catalyzes conversion of hydrogen peroxide to water and molecular oxygen, protecting cells against oxidative stress. The aim of this study was to investigate the possible association between CAT C262T polymorphism in the promoter region of the CAT gene and leukemia risk and to determine the relationship between CAT genotypes and CAT enzyme activities. MATERIAL AND METHODS: Genotypes of 102 cases and 112 healthy controls’ genotypes were determined by polymerase chain reaction-restriction fragment length polymorphism methods. Catalase activity was measured with the method of Aebi. RESULTS: The frequencies of the T allele among the cases and controls were 28.4% and 25.9%, respectively (p = 0.75). The frequencies of CC, CT, and TT among cases were 57.8%, 27.4%, and 14.7%, respectively, while in controls, the frequencies of CC, CT, and TT were 54.4%, 39.3%, and 6.3%, respectively, which were not significantly different. Although CAT enzyme activity was lower in leukemia patients with TT genotypes than in controls, this did not reach statistical significance (p = 0.37). CONCLUSIONS: This is the first report showing that CAT C262T polymorphism is not a genetic predisposing factor for the risk of leukemia in the Turkish population. However, additional research is needed to confirm these findings. Termedia Publishing House 2019-11-12 /pmc/articles/PMC8314395/ /pubmed/34336022 http://dx.doi.org/10.5114/aoms.2019.89692 Text en Copyright: © 2019 Termedia & Banach https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license. |
spellingShingle | Clinical Research Eras, Nazan Türkoz, Gozde Tombak, Anil Tiftik, Naci Yalin, Serap Berkoz, Mehmet Erden, Sema Akbas, Etem An investigation of the relation between catalase C262T gene polymorphism and catalase enzyme activity in leukemia patients |
title | An investigation of the relation between catalase C262T gene polymorphism and catalase enzyme activity in leukemia patients |
title_full | An investigation of the relation between catalase C262T gene polymorphism and catalase enzyme activity in leukemia patients |
title_fullStr | An investigation of the relation between catalase C262T gene polymorphism and catalase enzyme activity in leukemia patients |
title_full_unstemmed | An investigation of the relation between catalase C262T gene polymorphism and catalase enzyme activity in leukemia patients |
title_short | An investigation of the relation between catalase C262T gene polymorphism and catalase enzyme activity in leukemia patients |
title_sort | investigation of the relation between catalase c262t gene polymorphism and catalase enzyme activity in leukemia patients |
topic | Clinical Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314395/ https://www.ncbi.nlm.nih.gov/pubmed/34336022 http://dx.doi.org/10.5114/aoms.2019.89692 |
work_keys_str_mv | AT erasnazan aninvestigationoftherelationbetweencatalasec262tgenepolymorphismandcatalaseenzymeactivityinleukemiapatients AT turkozgozde aninvestigationoftherelationbetweencatalasec262tgenepolymorphismandcatalaseenzymeactivityinleukemiapatients AT tombakanil aninvestigationoftherelationbetweencatalasec262tgenepolymorphismandcatalaseenzymeactivityinleukemiapatients AT tiftiknaci aninvestigationoftherelationbetweencatalasec262tgenepolymorphismandcatalaseenzymeactivityinleukemiapatients AT yalinserap aninvestigationoftherelationbetweencatalasec262tgenepolymorphismandcatalaseenzymeactivityinleukemiapatients AT berkozmehmet aninvestigationoftherelationbetweencatalasec262tgenepolymorphismandcatalaseenzymeactivityinleukemiapatients AT erdensema aninvestigationoftherelationbetweencatalasec262tgenepolymorphismandcatalaseenzymeactivityinleukemiapatients AT akbasetem aninvestigationoftherelationbetweencatalasec262tgenepolymorphismandcatalaseenzymeactivityinleukemiapatients AT erasnazan investigationoftherelationbetweencatalasec262tgenepolymorphismandcatalaseenzymeactivityinleukemiapatients AT turkozgozde investigationoftherelationbetweencatalasec262tgenepolymorphismandcatalaseenzymeactivityinleukemiapatients AT tombakanil investigationoftherelationbetweencatalasec262tgenepolymorphismandcatalaseenzymeactivityinleukemiapatients AT tiftiknaci investigationoftherelationbetweencatalasec262tgenepolymorphismandcatalaseenzymeactivityinleukemiapatients AT yalinserap investigationoftherelationbetweencatalasec262tgenepolymorphismandcatalaseenzymeactivityinleukemiapatients AT berkozmehmet investigationoftherelationbetweencatalasec262tgenepolymorphismandcatalaseenzymeactivityinleukemiapatients AT erdensema investigationoftherelationbetweencatalasec262tgenepolymorphismandcatalaseenzymeactivityinleukemiapatients AT akbasetem investigationoftherelationbetweencatalasec262tgenepolymorphismandcatalaseenzymeactivityinleukemiapatients |